[ad_1] narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency…
Browsing: Therapeutics
[ad_1] narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency…
[ad_1] Eliem Therapeutics (NASDAQ:ELYM) has introduced the appointments of Brett Kaplan as COO and Nishi Rampal as Senior Vice President, Clinical Development. Most not too long…
[ad_1] narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency…
[ad_1] Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q [ad_2] Source: Seekingalpha
[ad_1] Eliem Therapeutics (NASDAQ:ELYM) has introduced the appointments of Brett Kaplan as COO and Nishi Rampal as Senior Vice President, Clinical Development. Most not too long…
[ad_1] Altamira Therapeutics extends distribution agreement with Pharma Nordic [ad_2] Source: Seekingalpha
[ad_1] Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q [ad_2] Source: Seekingalpha
[ad_1] Altamira Therapeutics extends distribution agreement with Pharma Nordic [ad_2] Source: Seekingalpha
[ad_1] Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q [ad_2] Source: Seekingalpha